AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2007
Jun 19, 2007
34519_dirs_2007-06-19_e979fea9-00f0-4f03-a76a-32330c54eb97.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2007-06-19
Reporting Person: Rhodes Linda (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-06-19 | Common stock, $0.10 par value | M | 2000 | $4.67 | Acquired | 2000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-06-19 | Non-qualified stock option (Right to Buy) | $4.67 | M | 2000 | Disposed | 2010-08-22 | Common Stock (2000) | Direct |
Footnotes
F1: This option vests according to the following schedule, provided that Optionee is re-elected as a director at each such meeting:
(i) 5,000 shares on and after the 2006 Annual Meeting of Shareholders;
(ii) an additional 5,000 shares on and after the 2007 Annual Meeting of Shareholders; and
(iii) the remaining 5,000 shares on and after the 2008 Annual Meeting of Shareholders.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23